Contezolid in complicated skin and soft tissue infection.
Sign Up to like & getrecommendations! Published in 2022 at "Drugs of today"
DOI: 10.1358/dot.2022.58.7.3389002
Abstract: Contezolid (MRX-I, Youxitai) is an oral oxazolidinone drug being developed by MicuRx Pharmaceutical Co., Ltd., Shanghai, China. It was approved by China's National Medical Products Administration (NMPA) in June 2021, attaining its first approval for… read more here.
Keywords: complicated skin; contezolid complicated; soft tissue; tissue infection ... See more keywords